MetaADEDB 2.0 @ LMMD
Pravastatin
(VWBQYTRBTXKKOG-IYNICTALSA-M)
Structure
SMILES
CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)[O-])O)O)[C@H](C=C2)C)C.[Na+]
Molecular Formula:
C23H35NaO7
Molecular Weight:
446.510
Log P:
1.1057
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
127.12
CAS Number(s):
81131-70-6
Synonym(s)
1.
Pravastatin
2.
Eptastatin
3.
Apo-Pravastatin
4.
Bristacol
5.
CS-514
6.
Elisor
7.
Lin-Pravastatin
8.
Lipemol
9.
Liplat
10.
Lipostat
11.
Mevalotin
12.
Nu-Pravastatin
13.
Prareduct
14.
Pravachol
15.
Pravacol
16.
Pravasin
17.
Pravastatin Monosodium Salt, (6 beta)-Isomer
18.
Pravastatin Sodium
19.
Pravastatin Sodium Salt
20.
Pravastatin tert-Octylamine Salt
21.
Pravastatin, (6 beta)-Isomer
22.
RMS-431
23.
SQ-31,000
24.
SQ-31000
25.
Selektine
26.
Vasten
27.
Apo Pravastatin
28.
CS 514
29.
CS514
30.
Lin Pravastatin
31.
Nu Pravastatin
32.
Pravastatin tert Octylamine Salt
33.
RMS 431
34.
RMS431
35.
SQ 31,000
36.
SQ 31000
37.
SQ31,000
38.
SQ31000
39.
Sodium Salt, Pravastatin
External Link(s)
MeSHD017035
PubChem Compound16759173
ChEBI8361
CHEMBLCHEMBL690
KEGGdr:D00893
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MyalgiaFAERS: 137
Canada Vigilance: 10
Canada Vigilance
US FAERS
2Drug ineffectiveFAERS: 40US FAERS
3ArthralgiaFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
4HypersensitivityFAERS: 30US FAERS
5Blood creatine phosphokinase increasedFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
6AstheniaFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
7FatigueFAERS: 26
Canada Vigilance: 4
Canada Vigilance
US FAERS
8HeadacheFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
9PainFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
10AlopeciaFAERS: 25US FAERS
11DizzinessFAERS: 22
Canada Vigilance: 3
Canada Vigilance
US FAERS
12NauseaFAERS: 21US FAERS
13Blood cholesterol increasedFAERS: 16US FAERS
14AmnesiaFAERS: 15US FAERS
15Chest PainFAERS: 13US FAERS
16RhabdomyolysisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Back PainFAERS: 12US FAERS
18MalaiseFAERS: 11US FAERS
19Memory impairmentFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
20FlatulenceFAERS: 10US FAERS
21Musculoskeletal PainFAERS: 10US FAERS
22Medication ErrorFAERS: 9US FAERS
23Product substitution issueFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
24PruritusFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
25ConstipationFAERS: 8US FAERS
26PalpitationsFAERS: 8US FAERS
27Abdominal PainFAERS: 7US FAERS
28Autoimmune hepatitisFAERS: 7US FAERS
29Blood triglycerides increasedFAERS: 7US FAERS
30Cerebrovascular accidentFAERS: 7US FAERS
31Diabetes MellitusFAERS: 7US FAERS
32DyspepsiaFAERS: 7US FAERS
33Muscle CrampFAERS: 7US FAERS
34MyopathyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
35jaundiceFAERS: 7US FAERS
36muscle injuryFAERS: 7US FAERS
37AbasiaFAERS: 6US FAERS
38Abdominal discomfortFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
39Aspartate Aminotransferase IncreasedFAERS: 6US FAERS
40Chest discomfortFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
41DysgeusiaFAERS: 6US FAERS
42Feeling abnormalFAERS: 6US FAERS
43Neck PainFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
44SwellingFAERS: 6US FAERS
45TinnitusFAERS: 6US FAERS
46Alanine Aminotransferase IncreasedFAERS: 5US FAERS
47Blood cholesterol abnormalFAERS: 5US FAERS
48Burning sensationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Musculoskeletal stiffnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Myocardial InfarctionFAERS: 5US FAERS
51Peripheral swellingFAERS: 5US FAERS
52PneumoniaFAERS: 5US FAERS
53Product taste abnormalFAERS: 5US FAERS
54UrticariaFAERS: 5US FAERS
55VomitingFAERS: 5US FAERS
56Adverse eventFAERS: 4US FAERS
57Atrial FibrillationFAERS: 4US FAERS
58DiplopiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
59HepatitisFAERS: 4US FAERS
60Limb discomfortFAERS: 4US FAERS
61Myasthenia GravisFAERS: 4US FAERS
62MyositisFAERS: 4US FAERS
63Nerve injuryFAERS: 4US FAERS
64Oropharyngeal painFAERS: 4US FAERS
65Pharmaceutical product complaintFAERS: 4US FAERS
66PregnancyFAERS: 4US FAERS
67Product quality issueFAERS: 4US FAERS
68StressFAERS: 4US FAERS
69TremorFAERS: 4US FAERS
70Weight decreasedFAERS: 4US FAERS
71Activities of daily living impairedFAERS: 3US FAERS
72AgeusiaFAERS: 3US FAERS
73Amyotrophic Lateral SclerosisFAERS: 3US FAERS
74AnxietyFAERS: 3US FAERS
75ArthropathyFAERS: 3US FAERS
76Blood lactate dehydrogenase increasedFAERS: 3US FAERS
77CataractFAERS: 3US FAERS
78ChillsFAERS: 3US FAERS
79ChromaturiaFAERS: 3US FAERS
80Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
81Impaired work abilityFAERS: 3US FAERS
82LethargyFAERS: 3US FAERS
83Muscle FatigueFAERS: 3US FAERS
84Musculoskeletal discomfortFAERS: 3US FAERS
85PancreatitisFAERS: 3US FAERS
86Pulmonary FibrosisFAERS: 3US FAERS
87Reaction to drug excipientsFAERS: 3US FAERS
88Skin UlcerFAERS: 3US FAERS
89Walking aid userFAERS: 3US FAERS
90nervous system disorderFAERS: 3US FAERS
91AcneFAERS: 2US FAERS
92Anaphylactic shockFAERS: 2US FAERS
93AngerFAERS: 2US FAERS
94AngioedemaFAERS: 2US FAERS
95AnosmiaFAERS: 2US FAERS
96Apparent deathFAERS: 2US FAERS
97ArthritisFAERS: 2US FAERS
98AscitesFAERS: 2US FAERS
99Back disorderFAERS: 2US FAERS
100Blood creatinine increasedFAERS: 2US FAERS
101Blood glucose increasedFAERS: 2US FAERS
102Blood pressure fluctuationFAERS: 2US FAERS
103Bone painFAERS: 2US FAERS
104Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
105ColitisFAERS: 2US FAERS
106Congenital choroid plexus cystFAERS: 2US FAERS
107Coronary Artery DiseaseFAERS: 2US FAERS
108Dry skinFAERS: 2US FAERS
109DysphoniaFAERS: 2US FAERS
110DysuriaFAERS: 2US FAERS
111EpistaxisFAERS: 2US FAERS
112Erectile dysfunctionFAERS: 2US FAERS
113Global AmnesiaFAERS: 2US FAERS
114HepatotoxicityFAERS: 2US FAERS
115Hypoaesthesia facialFAERS: 2US FAERS
116HypothyroidismFAERS: 2US FAERS
117Incorrect dose administeredFAERS: 2US FAERS
118InfluenzaFAERS: 2US FAERS
119Joint stiffnessFAERS: 2US FAERS
120Lip swellingFAERS: 2US FAERS
121Low birth weight babyFAERS: 2US FAERS
122Muscle enzyme increasedFAERS: 2US FAERS
123Muscle strainFAERS: 2US FAERS
124Muscle tightnessFAERS: 2US FAERS
125NeuralgiaFAERS: 2US FAERS
126NeuropathyFAERS: 2US FAERS
127OphthalmoplegiaFAERS: 2US FAERS
128Pericardial effusionFAERS: 2US FAERS
129Polymyalgia RheumaticaFAERS: 2US FAERS
130RestlessnessFAERS: 2US FAERS
131Rheumatoid ArthritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Serum SicknessFAERS: 2US FAERS
133Sexual DysfunctionFAERS: 2US FAERS
134StomatitisFAERS: 2US FAERS
135SyncopeFAERS: 2US FAERS
136Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
137Throat irritationFAERS: 2US FAERS
138Urinary RetentionFAERS: 2US FAERS
139Vitamin D DeficiencyFAERS: 2US FAERS
140Wheelchair userFAERS: 2US FAERS
141Wrong technique in product usage processFAERS: 2US FAERS
142Accidental exposureFAERS: 1US FAERS
143Accidental overdoseFAERS: 1US FAERS
144AgitationFAERS: 1US FAERS
145Aldolase increasedFAERS: 1US FAERS
146Allergic coughFAERS: 1US FAERS
147Androgenetic AlopeciaFAERS: 1US FAERS
148Angina PectorisFAERS: 1US FAERS
149Anti-transglutaminase antibody increasedFAERS: 1US FAERS
150AphasiaFAERS: 1US FAERS
151Aphthous StomatitisFAERS: 1US FAERS
152AtelectasisFAERS: 1US FAERS
153Atrial tachycardiaFAERS: 1US FAERS
154AzoospermiaFAERS: 1US FAERS
155BedriddenFAERS: 1US FAERS
156Bladder painFAERS: 1US FAERS
157Blood creatine phosphokinase abnormalFAERS: 1US FAERS
158Blood sodium increasedFAERS: 1US FAERS
159BradycardiaFAERS: 1US FAERS
160Breast tendernessFAERS: 1US FAERS
161CachexiaFAERS: 1US FAERS
162CalcinosisFAERS: 1US FAERS
163Cardiac FlutterFAERS: 1US FAERS
164Cardiac enzymes increasedFAERS: 1US FAERS
165Carpal Tunnel SyndromeFAERS: 1US FAERS
166Central nervous system lesionFAERS: 1US FAERS
167CheilitisFAERS: 1US FAERS
168Chest wall painFAERS: 1US FAERS
169CholecystitisFAERS: 1US FAERS
170CholelithiasisFAERS: 1US FAERS
171CholestasisFAERS: 1US FAERS
172Cold sweatFAERS: 1US FAERS
173Completed SuicideFAERS: 1US FAERS
174Contraindicated product administeredFAERS: 1US FAERS
175DeafnessFAERS: 1US FAERS
176DehydrationFAERS: 1US FAERS
177DementiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Dental cariesFAERS: 1US FAERS
179Depressed Level of ConsciousnessFAERS: 1US FAERS
180DermatomyositisFAERS: 1US FAERS
181DisorientationFAERS: 1US FAERS
182Disseminated Intravascular CoagulationFAERS: 1US FAERS
183Dissociative disorderFAERS: 1US FAERS
184Drug administration errorFAERS: 1US FAERS
185Drug toxicityFAERS: 1US FAERS
186Duodenal UlcerFAERS: 1US FAERS
187DysarthriaFAERS: 1US FAERS
188EczemaFAERS: 1US FAERS
189Emotional distressFAERS: 1US FAERS
190EosinophiliaFAERS: 1US FAERS
191EructationFAERS: 1US FAERS
192Erythema NodosumFAERS: 1US FAERS
193ErythemaFAERS: 1US FAERS
194Eye irritationFAERS: 1US FAERS
195Eye painFAERS: 1US FAERS
196Feeling ColdFAERS: 1US FAERS
197Feeling jitteryFAERS: 1US FAERS
198Flank PainFAERS: 1US FAERS
199Fluid overloadFAERS: 1US FAERS
200FlushingFAERS: 1US FAERS
201Foreign body in respiratory tractFAERS: 1US FAERS
202FractureFAERS: 1US FAERS
203FrustrationFAERS: 1US FAERS
204GastritisFAERS: 1US FAERS
205GlaucomaFAERS: 1US FAERS
206GoutFAERS: 1US FAERS
207Grip strength decreasedFAERS: 1US FAERS
208HepatomegalyFAERS: 1US FAERS
209Hyaluronic acid increasedFAERS: 1US FAERS
210HypersomniaFAERS: 1US FAERS
211HypogeusiaFAERS: 1US FAERS
212HypokinesiaFAERS: 1US FAERS
213ImmobileFAERS: 1US FAERS
214Impaired driving abilityFAERS: 1US FAERS
215Incorrect storage of drugFAERS: 1US FAERS
216Increased tendency to bruiseFAERS: 1US FAERS
217InfertilityFAERS: 1US FAERS
218Intercepted drug dispensing errorFAERS: 1US FAERS
219Intervertebral Disc DegenerationFAERS: 1US FAERS
220Irritable Bowel SyndromeFAERS: 1US FAERS
221Joint Range of Motion DecreasedFAERS: 1US FAERS
222Large intestine perforationFAERS: 1US FAERS
223Ligament injuryFAERS: 1US FAERS
224Low density lipoprotein increasedFAERS: 1US FAERS
225Lung consolidationFAERS: 1US FAERS
226MeningiomaFAERS: 1US FAERS
227Mental impairmentFAERS: 1US FAERS
228Mental status changesFAERS: 1US FAERS
229Middle insomniaFAERS: 1US FAERS
230Mood swingsFAERS: 1US FAERS
231Multiple MyelomaFAERS: 1US FAERS
232MyocarditisFAERS: 1US FAERS
233NasopharyngitisFAERS: 1US FAERS
234NecrosisFAERS: 1US FAERS
235NervousnessFAERS: 1US FAERS
236NeutropeniaFAERS: 1US FAERS
237Night sweatsFAERS: 1US FAERS
238No adverse effectFAERS: 1US FAERS
239Non-cardiac chest painFAERS: 1US FAERS
240Obsessive-Compulsive DisorderFAERS: 1US FAERS
241Paranasal sinus hypersecretionFAERS: 1US FAERS
242PeriarthritisFAERS: 1US FAERS
243PhotophobiaFAERS: 1US FAERS
244PolyarthritisFAERS: 1US FAERS
245PolymyalgiaFAERS: 1US FAERS
246Poor quality sleepFAERS: 1US FAERS
247Pre-existing condition improvedFAERS: 1US FAERS
248Pregnancy on contraceptiveFAERS: 1US FAERS
249PresyncopeFAERS: 1US FAERS
250Product counterfeitFAERS: 1US FAERS
251Product physical issueFAERS: 1US FAERS
252Product size issueFAERS: 1US FAERS
253Product solubility abnormalFAERS: 1US FAERS
254Product use in unapproved indicationFAERS: 1US FAERS
255Product use issueFAERS: 1US FAERS
256Protein urine presentFAERS: 1US FAERS
257PsoriasisFAERS: 1US FAERS
258Pulmonary thrombosisFAERS: 1US FAERS
259Purpura FulminansFAERS: 1US FAERS
260PurpuraFAERS: 1US FAERS
261Quality of life decreasedFAERS: 1US FAERS
262Rash erythematousFAERS: 1US FAERS
263Renal tubular necrosisFAERS: 1US FAERS
264Respiratory distressFAERS: 1US FAERS
265Restless Legs SyndromeFAERS: 1US FAERS
266RetchingFAERS: 1US FAERS
267Retinal DetachmentFAERS: 1US FAERS
268Retroperitoneal fibrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
269RhabdomyomaFAERS: 1US FAERS
270RhinitisFAERS: 1US FAERS
271Rotator cuff syndromeFAERS: 1US FAERS
272Sacral painFAERS: 1US FAERS
273SciaticaFAERS: 1US FAERS
274Semen abnormalFAERS: 1US FAERS
275SepsisFAERS: 1US FAERS
276Septic embolusFAERS: 1US FAERS
277Skin indentationFAERS: 1US FAERS
278Skin lesionFAERS: 1US FAERS
279Skin necrosisFAERS: 1US FAERS
280Spontaneous penile erectionFAERS: 1US FAERS
281Stevens-Johnson SyndromeFAERS: 1US FAERS
282Suicide attemptFAERS: 1US FAERS
283Supraventricular tachycardiaFAERS: 1US FAERS
284ThirstFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
285ThrombocytopeniaFAERS: 1US FAERS
286ThrombophlebitisFAERS: 1US FAERS
287ThrombosisFAERS: 1US FAERS
288ToothacheFAERS: 1US FAERS
289Toxic Epidermal NecrolysisFAERS: 1US FAERS
290Toxicity to various agentsFAERS: 1US FAERS
291Unevaluable eventFAERS: 1US FAERS
292Urinary tract infectionFAERS: 1US FAERS
293VasculitisFAERS: 1US FAERS
294VertigoFAERS: 1US FAERS
295Visual ImpairmentFAERS: 1US FAERS
296WheezingFAERS: 1US FAERS
297White blood cell count decreasedFAERS: 1US FAERS
298Wrong technique in drug usage processFAERS: 1US FAERS
299Gait inabilityCanada Vigilance: 1Canada Vigilance
300HungerCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.